Sat Kartar Life Signs Strategic MOU with Jeena Sikho Lifecare for Healthcare Collaboration

2 min read     Updated on 15 Apr 2026, 09:34 AM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

Sat Kartar Life Limited entered into a strategic collaboration with Jeena Sikho Lifecare Limited, combining AI-driven patient acquisition systems with clinical healthcare infrastructure. The three-year agreement features a 15% revenue sharing model across all service categories and includes plans for developing Ayurveda hospitals in South India.

powered bylight_fuzz_icon
37735991

*this image is generated using AI for illustrative purposes only.

Sat Kartar Life Limited has entered into a Strategic Memorandum of Understanding with Jeena Sikho Lifecare Limited on April 14, 2026, pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The collaboration integrates Sat Kartar Life Limited's AI-driven patient acquisition ecosystem with Jeena Sikho Lifecare's clinical and institutional healthcare infrastructure to enhance efficiency, scalability, and patient outcomes.

Strategic Collaboration Framework

The MOU establishes a structured pipeline where patient identification, engagement, and funnelling are managed through Sat Kartar Life Limited's systems, while diagnosis, treatment, and healthcare delivery remain exclusively within the domain and control of Jeena Sikho Lifecare Limited. This arrangement ensures that clinical integrity is preserved and operational accountability remains clearly demarcated between the parties.

Aspect: Details
Collaboration Partner: Jeena Sikho Lifecare Limited
Agreement Date: April 14, 2026
Scope: Domestic healthcare collaboration
Term: Three years
Termination Notice: 30 days prior written notice

Revenue Sharing Structure

The agreement establishes a comprehensive revenue-sharing model where Sat Kartar Life Limited receives a percentage of billing values across different service categories from Jeena Sikho Lifecare Limited based on actual patient treatments and payments received.

Service Type: Revenue Share to Sat Kartar: Calculation Basis
OPD/Medicine Cases: 15% Net billing value (Total amount - GST - Discount)
IPD/Admission Cases: 15% Total bill value (excluding GST and discounts)
Recurring Treatment: 15% Continues till patient remains in active treatment

The revenue share is payable only after actual payment is received from patients, with exclusions for leads, appointments, non-converted patients, GST, discounts, and free treatments. Monthly reconciliation and transparent reporting mechanisms are established, with audit rights retained by Jeena Sikho Lifecare Limited.

Future Development Plans

The MOU records Sat Kartar Life Limited's intention to develop Ayurveda hospitals and healthcare centres, including in South India. Under potential separate agreements, Jeena Sikho Lifecare Limited may provide operational and management services for such facilities, while Sat Kartar Life Limited will handle infrastructure, capital investment, statutory compliances, licensing, and setup.

Market Positioning and Compliance

Company: Market Capitalization
Jeena Sikho Lifecare Limited: Rs. 8,268.48 crores
Sat Kartar Life Limited: Rs. 307.03 crores

The transaction does not fall within the definition of a Related Party Transaction under SEBI regulations, as Sat Kartar Life Limited and its promoters are not related to the promoters or promoter group of Jeena Sikho Lifecare Limited. No regulatory approvals are required at this stage, and the MOU does not create any partnership, joint venture, or agency relationship between the parties.

Key Terms and Digital Infrastructure

Under the collaboration framework, each party retains ownership of pre-existing data, while patient-related clinical data post consultation vests exclusively with Jeena Sikho Lifecare Limited. The parties will act as independent contractors, with Jeena Sikho Lifecare Limited maintaining responsibility and authority over clinical operations, medical protocols, treatment decisions, and patient care delivery in accordance with applicable medical and regulatory requirements.

The Board of Directors meeting to approve this MOU commenced at 8:30 P.M. (IST) and concluded at 9:30 P.M. (IST) on April 14, 2026, with Managing Director Manish Grover signing the disclosure documents.

Historical Stock Returns for Jeena Sikho Lifecare

1 Day5 Days1 Month6 Months1 Year5 Years
-0.22%+3.67%+16.77%-8.45%-70.69%+292.07%

How will the AI-driven patient acquisition system impact Sat Kartar Life's competitive positioning against other healthcare technology companies in the Indian market?

What are the potential scalability challenges and capital requirements for Sat Kartar Life's planned expansion of Ayurveda hospitals in South India?

Could this collaboration model be replicated with other healthcare providers to diversify Sat Kartar Life's revenue streams beyond the single partnership?

Jeena Sikho Lifecare Limited Files SEBI Compliance Certificate for Q4FY26

1 min read     Updated on 03 Apr 2026, 02:41 PM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

Jeena Sikho Lifecare Limited has filed its quarterly compliance certificate with NSE and BSE for Q4FY26 under SEBI Regulation 74(5). The certificate, issued by Skyline Financial Services Private Limited, confirms no physical share certificates were received for dematerialization during the quarter ended March 31, 2026. Managing Director Manish Grover submitted the compliance documents on April 3, 2026.

powered bylight_fuzz_icon
36753091

*this image is generated using AI for illustrative purposes only.

Jeena sikho lifecare Limited has filed its quarterly compliance certificate with the National Stock Exchange of India Limited and BSE Limited for the quarter ended March 31, 2026. The submission fulfills the company's regulatory obligations under SEBI (Depositories and Participants) Regulations 2018.

Regulatory Compliance Filing

The company submitted the certificate dated April 1, 2026, to both stock exchanges on April 3, 2026. Managing Director Manish Grover (DIN: 07557886) signed the compliance documents on behalf of Jeena Sikho Lifecare Limited from the company's registered office in Zirakpur, Punjab.

Filing Details: Information
Certificate Date: April 1, 2026
Submission Date: April 3, 2026
Quarter Ended: March 31, 2026
Regulation: SEBI Regulation 74(5)
Authorized Signatory: Manish Grover, Managing Director

Share Transfer Agent Confirmation

Skyline Financial Services Private Limited, serving as the company's Registrar and Share Transfer Agent, issued the compliance certificate. The certificate confirms that no physical share certificates were received for dematerialization of equity shares during the quarter ended March 31, 2026.

RTA Details: Information
Agent Name: Skyline Financial Services Private Limited
Certificate Reference: SFSPL/RTA/March/2026
Authorized Signatory: Parveen Sharma
Confirmation Status: No physical shares received

Stock Exchange Submissions

The compliance documents were simultaneously submitted to both major Indian stock exchanges where the company's shares are listed. The National Stock Exchange received the filing under symbol JSLI, while BSE received it under scrip code 544476.

Company Information

Jeena Sikho Lifecare Limited operates with its registered office in Zirakpur, Punjab, and corporate office in New Delhi. The company's CIN number is L52601PB2017PLC046545, and it maintains operations across multiple Ayurveda clinics and hospitals as indicated in its business description.

Historical Stock Returns for Jeena Sikho Lifecare

1 Day5 Days1 Month6 Months1 Year5 Years
-0.22%+3.67%+16.77%-8.45%-70.69%+292.07%

Will Jeena Sikho Lifecare's expansion of Ayurveda clinics and hospitals drive increased investor interest in physical share certificates for the upcoming quarters?

How might the company's zero physical share dematerialization trend impact its shareholder base composition and trading liquidity in FY 2026-27?

What strategic initiatives is Jeena Sikho Lifecare planning to announce in its upcoming annual results that could influence investor sentiment?

More News on Jeena Sikho Lifecare

1 Year Returns:-70.69%